Buy GLP-1 (SMA) 15mg Research Peptide OnlineGLP-1 (SMA) 15mg Product Specifications & StorageGLP-1 Receptor Agonist Analog (SMA designation) is a synthetic peptide engineered through site-specific modifications to enhance protease resistance and extend biological activity in preclinical research applications. This 31-amino-acid construct maintains high-affinity binding to GLP-1 receptors while demonstrating improved stability characteristics compared to native incretin peptides in laboratory models.GLP-1 (SMA) Published Research SummaryThe SMA structural design incorporates fatty acid conjugation and amino acid substitutions that reduce susceptibility to dipeptidyl peptidase-4 (DPP-4) and other proteolytic enzymes. This modification extends circulating presence in preclinical systems, enabling sustained investigation of GLP-1R-dependent signaling. Cell culture research demonstrates that GLP-1 (SMA) maintains full agonist activity at nanomolar concentrations, triggering GPCR-mediated phosphorylation cascades and cAMP elevation. In vivo preclinical studies by Wilkin et al. (2005) document that extended-activity GLP-1 analogs produce sustained metabolic effects with reduced dosing frequency compared to native GLP-1.GLP-1 (SMA) Mechanism of ActionPreclinical research characterizes GLP-1R signaling across multiple tissue compartments. Pancreatic beta cells respond to GLP-1 (SMA) with glucose-dependent insulin secretion increases. Gastrointestinal studies document delayed gastric emptying and reduced nutrient absorption rates through enterocyte and smooth muscle GLP-1R activation. Brain imaging studies in animal models indicate hypothalamic GLP-1R engagement following systemic administration.GLP-1 (SMA) 15mg is supplied as lyophilized powder in pharmaceutical research formulation. Reconstitute with sterile water or bacteriostatic saline; solutions remain active for 48 hours at 4°C. Unreconstituted powder maintains stability at 2-8°C for extended periods. Protect from light and freeze-thaw cycling to preserve peptide structure and functionality.This product is exclusively for preclinical research and in vitro use. Human administration, clinical investigation, and therapeutic use are prohibited. All research must comply with institutional biosafety guidelines and applicable regulatory requirements.
